Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing (Q47846447)

6 February 2018

title

Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing (English)

1 reference

6 February 2018

author name string

Lisa M Flick

1

1 reference

6 February 2018

Jason M Weaver

2

1 reference

6 February 2018

Michael Ulrich-Vinther

3

1 reference

6 February 2018

Faruk Abuzzahab

4

1 reference

6 February 2018

Xinping Zhang

5

1 reference

6 February 2018

William C Dougall

6

1 reference

6 February 2018

Dirk Anderson

7

1 reference

6 February 2018

Regis J O'Keefe

8

1 reference

6 February 2018

Edward M Schwarz

9

1 reference

6 February 2018

publication date

1 July 2003

1 reference

6 February 2018

Journal of Orthopaedic Research

published in

1 reference

6 February 2018

volume

21

1 reference

6 February 2018

issue

4

1 reference

6 February 2018

page(s)

676-684

1 reference

6 February 2018

Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

The effect of a single dose of osteoprotegerin in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Production of a standard closed fracture in laboratory animal bone

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

RANK is essential for osteoclast and lymph node development

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Skeletal Renewal and Metabolic Bone Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

A standardized experimental fracture in the mouse tibia

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Osteopetrosis, a New Recessive Skeletal Mutation on Chromosome 12 of the Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Effect of alendronate on fracture healing and bone remodeling in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900011-1

7 January 2021

10.1016/S0736-0266(03)00011-1

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018